Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies
Authors:
Open Access
- 12 November 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 7
Abstract
Aim: This systematic review and meta-analysis aimed to investigate the risk of cardiovascular disease (CVD) and cerebrovascular disease (CeVD) events in women with polycystic ovary syndrome (PCOS). Methods: We searched the literatures in Pubmed, Embase, and Web of Science to identify cohort studies reporting the association between PCOS and CVD/CeVD events from 1964 to June 1, 2020. Outcome variables, such as all-cause mortality, cardiovascular death, any cardiovascular diseases, myocardial infarction, ischemic heart disease, and stroke, were extracted from the identified literatures, and we reported the outcomes of the association in hazard ratios (HR) and odds ratios (OR). Results: Ten cohort studies comprising 166,682 samples are included in the review. Compared to non-PCOS women, the pooled risk of CVD events in PCOS women (OR: 1.66, 95% CI: 1.32–2.08). In addition, the risk of myocardial infarction (OR: 2.57, 95% CI: 1.37–4.82), ischemic heart disease (OR: 2.77, 95% CI: 2.12–3.61), and stroke (OR: 1.96, 95% CI: 1.56–2.47) are higher in the PCOS group. However, no significant difference in the overall mortality (HR: 1.04, 95% CI: 0.57–1.86) and CVD-related death (HR: 1.49, 95% CI: 0.99–2.23) was observed. Funnel plots of all outcomes are roughly symmetric, and no significant publication bias was found. Conclusion: Though this study identified an increased risk of CVD and CeVD among women with PCOS, including occurrence of myocardial infarction, ischemic heart disease, and stroke, there was no difference in the all-cause or CVD-related mortality observed. Further large-scale studies are warranted to strengthen the association between PCOS and CV events. Our study may require a larger sample size to further verify the conclusions.Keywords
This publication has 46 references indexed in Scilit:
- Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of AgeThe Journal of Clinical Endocrinology & Metabolism, 2009
- Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome EvaluationThe Journal of Clinical Endocrinology & Metabolism, 2008
- The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion ofPPAR-PPAR Research, 2007
- Polycystic ovary syndrome: A follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15–25 years after ovarian wedge resectionGynecological Endocrinology, 2007
- Synergic action of insulin and genistein on Na+/K+/2Cl − cotransporter in renal epitheliumBiochemical and Biophysical Research Communications, 2005
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomesStatistics in Medicine, 2002
- Meta-analysis, funnel plots and sensitivity analysisBiostatistics, 2000
- How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?Clinical Endocrinology, 1992
- Impaired Glucose Tolerance in Patients with Polycystic Ovary Syndrome (PCOS)Hormone Research, 1990